Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engages in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.
How did ASBP's recent EPS compare to expectations?
The most recent EPS for Aspire Biopharma Holdings Inc is $, expectations of $.
How did Aspire Biopharma Holdings Inc ASBP's revenue perform in the last quarter?
Aspire Biopharma Holdings Inc revenue for the last quarter is $
What is the revenue estimate for Aspire Biopharma Holdings Inc?
According to of Wall street analyst, the revenue estimate of Aspire Biopharma Holdings Inc range from $ to $
What's the earning quality score for Aspire Biopharma Holdings Inc?
Aspire Biopharma Holdings Inc has a earning quality score of C/6.918459. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Aspire Biopharma Holdings Inc report earnings?
Aspire Biopharma Holdings Inc next earnings report is expected in
What are Aspire Biopharma Holdings Inc's expected earnings?
Aspire Biopharma Holdings Inc expected earnings is $, according to wall-street analysts.
Did Aspire Biopharma Holdings Inc beat earnings expectations?
Aspire Biopharma Holdings Inc recent earnings of $ expectations.
